Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells

Journal of Immunology

Volumn 168, Issue 8, 2002, Pages 3865-3873

  Snyder, Christopher M ^a   Zhang, Xianghua ^a   Wysocki, Lawrence J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; EPITOPE; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; ASSAY; B LYMPHOCYTE ACTIVATION; CELL CULTURE; CELL TRANSPORT; CLONAL ANERGY; CONTROLLED STUDY; GENETIC CODE; HYBRIDOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE;

EID: 0037090314     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.8.3865     Document Type: Article

References (83)

1. Igα and Igβ are required for efficient trafficking to late endosomes and to enhance antigen presentation
2. Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: Importance depends on the nature of the antigen-Ab interaction
3. B cell antigen receptor signaling links biochemical changes in the class II peptide-loading compartment to enhanced processing
4. MHC class II antigen processing in B cells: Accelerated intracellular targeting of antigens
5. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes
6. Engagement of B cell receptor regulates the invariant chain-dependent MHC class II presentation pathway
7. Signaling through the B cell antigen receptor regulates discrete steps in the antigen processing pathway
8. Anti-immunoglobulin augments the B-cell antigen-presentation function independently of internalization of receptor-antigen complex
9. Receptor-mediated B cell antigen processing: Increased antigenicity of a globular protein covalently coupled to Abs specific for B cell surface structures
10. Antigen presentation by splenic B cells: Resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses
11. B cells as antigen-presenting cells: The requirement for B cell activation
12. Antigen presentation by resting B cells: Radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation
13. Presentation of antigen by B cells: Functional dependence on radiation dose, interleukins, cellular activation, and differential glycosylation
14. Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking
15. Endocytosis, intracellular trafficking, and processing of membrane IgG and monovalent antigen/membrane IgG complexes in B lymphocytes
16. T cell recognition of endogenous IgG2a expressed in B lymphoma cells
17. T cell clones specific for IgG2a of the a allotype: Direct evidence for presentation of endogenous antigen
18. Immunoglobulin-specific T-B cell interaction. I. Presentation of self immunoglobulin determinants by B lymphocytes
19. Presentation of endogenous immunoglobulin determinant to immunoglobulin-recognizing T cell clones by the thymic cells
20. - T cell clones of the ThI subset selectively suppress the IgH-Ib allotype in vivo
21. Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells
22. Resting B lymphocytes as APC for naive T lymphocytes: Dependence on CD40 ligand/CD40
23. Role of membrane immunoglobulin (Ig) crosslinking in membrane Ig-mediated, major histocompatibility-restricted T cell-B cell cooperation
24. Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes
25. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens
26. Parameters of tolerance induction by antigen targeted to B lymphocytes
27. Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells
28. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal Ab
29. An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness
30. Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
31. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
32. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
33. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation
34. CD40 ligand induction on T cell subsets by peptide-presenting B cells: Implications for development of the primary T and B cell response
35. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells
36. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
37. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by la-restricted Th2 helper T cell lines
38. Early changes in quiescent B cell physiology subsequent to cognate and bystander interaction with helper T cells
39. Supernatant from a cloned helper T cell stimulates most small resting B cells to undergo increased 1-A expression, blastogenesis, and progression through cell cycle
40. Effect of γ radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect
41. Antigen presentation by resting B cells: Effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy
42. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice
43. Role of interleukin 12 and costimulators in T cell anergy in vivo
44. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement
45. Th2 cell clonal anergy as a consequence of partial activation
46. The processing and presentation of the self-antigen hemoglobin: Self-reactivity can be limited by antigen availability and costimulator expression
47. T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315)
48. + T cells confer idiotype-specific tumor resistance in the absence of Abs
49. + T cells in vivo
50. MHC class II-restricted presentation of intracellular antigen
51. T cell recognition and tolerance of Ab diversity
52. T cell recognition of somatically generated Ab diversity
53. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive
54. Properties and applications of monoclonal Abs directed against determinants of they Thy-1 locus
55. "Panning" for lymphocytes: A method for cell selection
56. Influence of clonal selection on the expression of immunoglobulin variable region genes
57. Idiotype connectance in the immune system. I. Expression of a cross-reactive idiotype on induced antip-azophenylarsonate Abs and on endogenous Abs not specific for arsonate
58. The minimal number of antigenmajor histocompatibility complex class II complexes required for activation of naive and primed T cells
59. The minimal number of class II MHC-antigen complexes needed for T cell activation
60. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation
61. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments
62. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain
63. Naive versus memory CD4 T cell response to antigen: Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells
64. B cells turn off virgin but not memory T cells
65. Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients
66. Clonal deletion of specific thymocytes by an immunoglobulin idiotype
67. The roles of CD28 and CD40 ligand in T cell activation and tolerance
68. Mechanisms of peripheral T cell tolerance
69. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
70. Class II MHC molecules and antigen enter the same vesicles during internalization by resting B lymphocytes
71. Antigen entry into early endosomes is insufficient for MHC class II processing
72. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class H molecules
73. Natural adjuvants: Endogenous activators of dendritic cells
74. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
75. Transport of peptide-MHC class complexes in developing dendritic cells
76. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions
77. Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo
78. + T cells
79. Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice
80. Immunoglohulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells
81. + T cells
82. Antigen-stimulated dissociation of BCR mlg from Igα/Igβ: Implications for receptor desensitization
83. B cell antigen receptor desensitization: Disruption of receptor coupling to tyrosine kinase activation